Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the treatment of Relapsing-Remitting Multiple Sclerosis (MS)
Teva Pharmaceutical Industries Ltd. - Home | Facebook
Montreal, October 18, 2016 Re: PMPRB Guidelines Modernization Teva Canada Innovation and Teva Canada Limited, Canadian subsidia
Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease
Generic Viagra Manufacturers: Companies that Produce Sildenafil Drugs - Canadian Health&Care Mall™
Teva Canada Provides New Patient Resource to Empower Those Living with Chronic Conditions | Business Wire
Federal Court Clarifies Right of Action under Subsection 6(1) of PM(NOC) Regulations
Multiple Sclerosis: What the Family Physician Should Know... Michael M.C. Yeung, MD, FRCPC Director, MS Clinical Trials Research Program Clinical Associate. - ppt download
Health Canada Notice: ALERTEC (Modafinil) linked to risks of Congenital Anomalies